![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients Lonza Signs API Manufacturing Deal with Elan9:04 AM MST | December 8, 2011 | Deepti Ramesh Biotechnology company Elan (Dublin) says it has entered into a manufacturing agreement with Lonza for the supply of the active pharmaceutical ingredient (API) for ELND005, which is being developed by Elan for the treatment of Alzheimer's... This information is only available to Chemical Week subscribers. Forgot your user ID or password?
|
Not an IHS Chemical Week
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|